(Verbatim from the application): This is a competitive renewal application to fund the next five years of a longstanding research program whose general goal is the determination of the mechanisms and functional significance of PKC dependent contraction of differentiated vascular smooth muscle. The next period of support will focus on the interaction of PKC dependent signaling cascades with two actin-binding proteins, caldesmon and calponin; and the mechanisms by which members of the signaling cascades are targeted to subcellular locations.
The specific aims : (1) to test the hypothesis that calponin is a physiologically important regulator of smooth muscle contractility and to choose between the subhypotheses that: (a) calponin functions as an adaptor protein that links ERK1/2 to PKC versus (b) calponin directly regulates actomyosin interactions; (2) to test the hypothesis that CaP regulates the activation and/or substrate specificity of PKC in differentiated vascular smooth muscle cells.
This aim i s based on preliminary data showing that CaP can trigger phospholipid-independent autophosphorylation of PKC in vitro and that autophosphorylation is regulated in viva; (3) to further test the hypothesis that CaD is a physiologically important regulator of contractility and to test the sub-hypotheses that: (a) ERK1/2 regulates contractility in differentiated vascular smooth muscle via direct phosphorylation of CaD or (b) phosphorylation of CaD by ERK1/2 decreases the CaM requirement for disinhibition of CaD; (4) to investigate the mechanisms of ERK1/2 targeting by testing the hypotheses: (a) that MEK plays a role in the targeting of ERK1/2 in differentiated smooth muscle; (b) that phosphorylation-induced dimerization of ERK1/2 regulates its localization and (C) that CaP may act as an adaptor protein; (5) to test the specific hypothesis that caveolin acts as a scaffolding protein in a PKC-dependent pathway that regulates vascular tone by directing the subcellular targeting of members of this pathway. The experiments outlined in the proposal involve the use of multicellular strips, freshly, enzymatically isolated single cells from ferret aorta and ferret portal vein and purified proteins. The techniques to be used involve a newly developed application of an antisense approach for differentiated contractile smooth muscle as well as high-resolution digital confocal microscopy, microforce recording from single permeabilized cells, analytical ultracentrifugation, and a range of standard biochemical and molecular techniques. All techniques are established in the principal investigator's laboratory or home institution and the results are expected to significantly advance our understanding by which vascular tone is maintained. By working on differentiated rather than cultured vascular smooth muscle, the results on regulation of contractility will have direct relevance to cardiovascular disease. Additionally, novel information will be gained on targeting mechanisms that will be of broad relevance to the signal transduction community.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL042293-17
Application #
6717648
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Program Officer
Lin, Michael
Project Start
1989-04-01
Project End
2006-03-31
Budget Start
2004-04-01
Budget End
2006-03-31
Support Year
17
Fiscal Year
2004
Total Cost
$262,750
Indirect Cost
Name
Boston Biomedical Research Institute
Department
Type
DUNS #
058893371
City
Watertown
State
MA
Country
United States
Zip Code
02472
Li, Yunping; Gallant, Cynthia; Malek, Sabah et al. (2007) Focal adhesion signaling is required for myometrial ERK activation and contractile phenotype switch before labor. J Cell Biochem 100:129-40
Gallant, Cynthia; You, Jae Young; Sasaki, Yasuharu et al. (2005) MARCKS is a major PKC-dependent regulator of calmodulin targeting in smooth muscle. J Cell Sci 118:3595-605
Marganski, William A; Gangopadhyay, Samudra S; Je, Hyun-Dong et al. (2005) Targeting of a novel Ca+2/calmodulin-dependent protein kinase II is essential for extracellular signal-regulated kinase-mediated signaling in differentiated smooth muscle cells. Circ Res 97:541-9
Gangopadhyay, Samudra S; Takizawa, Norio; Gallant, Cynthia et al. (2004) Smooth muscle archvillin: a novel regulator of signaling and contractility in vascular smooth muscle. J Cell Sci 117:5043-57
Je, Hyun-Dong; Gallant, Cynthia; Leavis, Paul C et al. (2004) Caveolin-1 regulates contractility in differentiated vascular smooth muscle. Am J Physiol Heart Circ Physiol 286:H91-8
Li, Yunping; Je, Hyun-Dong; Malek, Sabah et al. (2004) Role of ERK1/2 in uterine contractility and preterm labor in rats. Am J Physiol Regul Integr Comp Physiol 287:R328-35
Gangopadhyay, Samudra S; Barber, Amy L; Gallant, Cynthia et al. (2003) Differential functional properties of calmodulin-dependent protein kinase IIgamma variants isolated from smooth muscle. Biochem J 372:347-57
Li, Yunping; Je, Hyun-Dong; Malek, Sabah et al. (2003) ERK1/2-mediated phosphorylation of myometrial caldesmon during pregnancy and labor. Am J Physiol Regul Integr Comp Physiol 284:R192-9
Shin, Heung-Mook; Je, Hyun-Dong; Gallant, Cynthia et al. (2002) Differential association and localization of myosin phosphatase subunits during agonist-induced signal transduction in smooth muscle. Circ Res 90:546-53
Je, H D; Gangopadhyay, S S; Ashworth, T D et al. (2001) Calponin is required for agonist-induced signal transduction--evidence from an antisense approach in ferret smooth muscle. J Physiol 537:567-77

Showing the most recent 10 out of 45 publications